Azusa, California


Purpose:

A study to evaluate the tolerability and acceptability of an investigational eye drop formulation in patients with Dry Eye Disease.


Criteria:

Inclusion Criteria: - Current use of an artificial tear product - Visual Acuity of at least 20/40 (while wearing glasses, if necessary). Exclusion Criteria: - Use of contact lenses in the last 3 months, or anticipated use of contact lenses during the study - Cataract surgery, laser-assisted in situ keratomileusis (LASIK), photorefractive keratectomy within 6 months - Use of RESTASIS® Cyclosporine Ophthalmic Emulsion or any topical cyclosporine within 3 months - Diagnosis of glaucoma.


NCT ID:

NCT02455050


Primary Contact:

Study Director
Medical Director
Allergan

Allergan Inc.
Email: clinicaltrials@allergan.com


Backup Contact:

N/A


Location Contact:

Azusa, California
United States



There is no listed contact information for this specific location.

Site Status: Recruiting


Data Source: ClinicalTrials.gov

Date Processed: January 21, 2020

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

If you would like to be contacted by the clinical trial representative please fill out the form below.